Cancer Research UK’s new data lands in a familiar spot. The charity has been tracking public hesitation toward red-flag symptoms for years. Each survey tends to show the same pattern: a significant minority sits on warning signs, and a chunk of those who do seek help drop the matter when symptoms persist.
The latest figures, released Tuesday, put the share of people ignoring possible cancer signs at one in three. Among those who managed to see a GP, 43% did not go back when their symptoms continued.
The eight symptoms monitored are standard: a changing mole, an unexplained lump, abnormal bleeding, a non-healing sore, blood in urine or stool, trouble swallowing, unexplained weight loss, and coughing up blood. Compare this to 2019. Back then, Cancer Research UK found nearly half of people surveyed had experienced a potential cancer symptom in the prior three months.
Roughly a third of them did not contact their doctor. The numbers have barely budged.
The same barriers reappear: trouble getting an appointment, deciding to manage the symptom alone, having other priorities. A 2015 study from the same charity offered a deeper look. Researchers interviewed people who had delayed seeing a doctor for possible cancer symptoms.
Common reasons included fear of wasting the GP’s time, fear of what might be found, and simple embarrassment. The current survey does not track fear directly, but the pattern holds. The new report mentions “difficulty getting an appointment” as a top barrier — a factor that has worsened since the pandemic stretched NHS capacity.
Michelle Mitchell, Cancer Research UK’s chief executive, stated the stakes plainly: “Nearly one in two of us will be diagnosed with cancer in our lifetime, that’s why it’s so important to spot cancer early – when treatment is more likely to be successful.” That line echoes what the charity has said for over a decade. Early detection improves survival odds.
It also reduces the need for aggressive treatment. Yet the public does not always act on that knowledge. The 2015 study found that people often rationalized delay.
They told themselves the symptom was probably nothing. They waited to see if it would go away.
They convinced themselves they were too busy. The new data suggests those habits remain entrenched. One detail from the current report deserves attention.
Over 90% of urgent GP referrals for suspected cancer turn out not to be cancer. That statistic cuts both ways. It should reassure people that most red-flag symptoms are benign.
It may also feed the hesitation — why bother the doctor if it is probably nothing? Cancer Research UK’s message is that the small chance of cancer makes the trip worthwhile.
The data shows that message is not fully landing. The charity has a new partner in this effort. Tesco pharmacists have received special training to help customers discuss potential cancer symptoms.
The scheme aims to lower one of the barriers — difficulty getting an appointment. A pharmacist is often easier to see than a GP.
Whether that changes behavior remains to be seen. Past initiatives have focused on public awareness campaigns, TV ads, and workplace programs. The results have been modest.
What stands out across these surveys is the consistency. The proportion of people who ignore symptoms has hovered around a third for at least a decade. The reasons given have not changed much.
The eight red-flag symptoms are the same ones the charity has promoted since the early 2000s. The challenge is not a lack of information.
It is a gap between knowing and doing.
{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Cancer Research UK survey finds 43% of patients do not revisit GP after symptoms persist”, “description”: “Cancer Research UK’s new data lands in a familiar spot. The charity has been tracking public hesitation toward red-flag symptoms for years. Each survey tends…”, “datePublished”: “2026-06-29T14:05:15+00:00T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “Maria Romano”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.2bme.xyz/”}}
